"LEF - Laboratório de Estudos Farmacêuticos, representing the Marketing Authorization Holder (Amdipharm Limited), will voluntarily recall the batches listed below of the medicines Liodimil, Maprotiline 25 mg, 50 mg, and 75 mg film-coated tablets from the Marketing Authorization Holder due to the detection of an impurity above the acceptable limit," reads the information circular available on the Infarmed website.

Infarmed further explains that the "manufacturer/MAH confirmed the presence of this quality defect in the indicated batches."

Infarmed states that "entities holding these batches of medicines in stock cannot sell, dispense, or administer them and must return them." "Patients taking medications from this/these batch(es) should not discontinue treatment."

However, they should, as soon as possible, "contact their doctor so that they can assess whether or not a replacement with an alternative medication is necessary."